GlassScriptPhysician profile
Faith Birnbaum
NPI 1972951986
$4,012.29
in general payments reported to CMS, 2019-2025
25 companies · $834 in 2025
The $834 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2021: $193 · 2022: $807 · 2023: $1,320 · 2024: $724 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,873 · Education: $4.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,872.74 |
| Education | $4.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,188.27 | 2022-2025 | Clareon, Hydrus Microstent, Rocklatan |
| Abbvie INC. | $778.49 | 2022-2025 | Xen Glaucoma Treatment System, Durysta, Lumigan |
| Bausch & Lomb Americas INC. | $504.45 | 2022-2025 | Miebo, Infuse, Vyzulta |
| Oyster Point Pharma, INC. | $331.38 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Horizon Therapeutics Plc | $215.70 | 2022-2023 | Tepezza |
| Amgen INC. | $149.26 | 2024-2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $148.32 | 2021 | |
| Glaukos Corporation | $109.99 | 2019-2024 | Idose |
| Mallinckrodt Hospital Products INC. | $93.13 | 2024-2025 | Acthar |
| Astellas Pharma US INC | $82.84 | 2024-2025 | Izervay |
| Allergan, INC. | $73.20 | 2019-2021 | |
| Dompe US, INC. | $52.29 | 2022-2024 | Oxervate |
| Apellis Pharmaceuticals, INC. | $34.83 | 2024-2025 | Syfovre |
| Sight Sciences, INC. | $31.97 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ani Pharmaceuticals, INC. | $25.28 | 2025 | Purified Cortrophin Gel |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $24.54 | 2024 | Tecnis Iol |
| Johnson & Johnson Vision Care, INC. | $24.05 | 2023 | Acuvue |
| Novartis Pharmaceuticals Corporation | $22.61 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.24 | 2021 | |
| Rayner Intraocular Lenses Limited | $19.04 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| New World Medical,INC. | $18.64 | 2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Lombart Brothers, INC. | $17.99 | 2023 | Opd-III |
| Thea Pharma INC. | $15.98 | 2025 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $14.66 | 2024 | |
| Biotissue Holdings INC. | $14.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faith Birnbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.